Breaking News Instant updates and real-time market news.

BUD

AB InBev

$63.33 /

+1.15 (+1.85%)

04:55
03/11/21
03/11
04:55
03/11/21
04:55

AB InBev management to meet virtually with Mizuho

Virtual Meeting to be held on March 11 hosted by Mizuho.

  • 11

    Mar

  • 23

    Mar

  • 06

    May

BUD AB InBev
$63.33 /

+1.15 (+1.85%)

03/01/21 Morgan Stanley
AB InBev price target lowered to EUR 56 from EUR 61 at Morgan Stanley
02/26/21 Barclays
AB InBev price target raised to EUR 59 from EUR 54 at Barclays
02/26/21 RBC Capital
AB InBev price target lowered to EUR 67 from EUR 71 at RBC Capital
02/26/21 Credit Suisse
AB InBev price target lowered to EUR 57 from EUR 61 at Credit Suisse

TODAY'S FREE FLY STORIES

Options
Bristol Myers Squibb call volume above normal and directionally bullish » 10:25
04/23/21
04/23
10:25
04/23/21
10:25
BMY

Bristol-Myers

$66.89 /

+0.57 (+0.86%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BMY Bristol-Myers
$66.89 /

+0.57 (+0.86%)

BMY Bristol-Myers
$66.89 /

+0.57 (+0.86%)

04/21/21 Citi
Citi sees 'material upside' for AbbVie, Bristol-Myers after Pfizer data
04/21/21 Citi
Citi opens '90-day catalyst watch' on Bristol-Myers, reiterates Buy
04/13/21 Truist
Bristol-Myers upgraded to Buy at Truist on improving pipeline asset visibility
04/13/21 Truist
Bristol-Myers upgraded to Buy from Hold at Truist
BMY Bristol-Myers
$66.89 /

+0.57 (+0.86%)

BMY Bristol-Myers
$66.89 /

+0.57 (+0.86%)

BMY Bristol-Myers
$66.89 /

+0.57 (+0.86%)

BMY Bristol-Myers
$66.89 /

+0.57 (+0.86%)

Conference/Events
Cowen pharmaceuticals analysts to hold analyst/industry conference call » 10:25
04/23/21
04/23
10:25
04/23/21
10:25
BMY

Bristol-Myers

$66.89 /

+0.57 (+0.86%)

Pharmaceuticals Analysts…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BMY Bristol-Myers
$66.89 /

+0.57 (+0.86%)

BMY Bristol-Myers
$66.89 /

+0.57 (+0.86%)

04/21/21 Citi
Citi sees 'material upside' for AbbVie, Bristol-Myers after Pfizer data
04/21/21 Citi
Citi opens '90-day catalyst watch' on Bristol-Myers, reiterates Buy
04/13/21 Truist
Bristol-Myers upgraded to Buy at Truist on improving pipeline asset visibility
04/13/21 Truist
Bristol-Myers upgraded to Buy from Hold at Truist
BMY Bristol-Myers
$66.89 /

+0.57 (+0.86%)

BMY Bristol-Myers
$66.89 /

+0.57 (+0.86%)

BMY Bristol-Myers
$66.89 /

+0.57 (+0.86%)

BMY Bristol-Myers
$66.89 /

+0.57 (+0.86%)

Conference/Events
Cantor Fitzgerald biopharma analysts hold an analyst/industry conference call » 10:25
04/23/21
04/23
10:25
04/23/21
10:25

Large Cap & Biopharma…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
UBS technology analyst to hold an analyst/industry conference call » 10:25
04/23/21
04/23
10:25
04/23/21
10:25

Technology Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Truist digital advertising analysts to hold analyst/industry conference call » 10:25
04/23/21
04/23
10:25
04/23/21
10:25

Digital Ad Analysts,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Allegiance Bancshares approves stock repurchase authorization up to 1M shares » 10:24
04/23/21
04/23
10:24
04/23/21
10:24
ABTX

Allegiance Bancshares

$39.02 /

+ (+0.00%)

On April 22, 2021, the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ABTX Allegiance Bancshares
$39.02 /

+ (+0.00%)

ABTX Allegiance Bancshares
$39.02 /

+ (+0.00%)

10/02/20 Janney Montgomery Scott
Allegiance Bancshares initiated with a Neutral at Janney Montgomery Scott
ABTX Allegiance Bancshares
$39.02 /

+ (+0.00%)

Recommendations
WeCommerce price target lowered to C$23 from C$26 at TD Securities » 10:23
04/23/21
04/23
10:23
04/23/21
10:23
WECMF

WeCommerce

$14.79 /

+0.4312 (+3.00%)

TD Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Allegiance Bancshares appoints Raimundo Riojas to board of directors » 10:23
04/23/21
04/23
10:23
04/23/21
10:23
ABTX

Allegiance Bancshares

$39.02 /

+ (+0.00%)

Allegiance Bancshares…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ABTX Allegiance Bancshares
$39.02 /

+ (+0.00%)

ABTX Allegiance Bancshares
$39.02 /

+ (+0.00%)

10/02/20 Janney Montgomery Scott
Allegiance Bancshares initiated with a Neutral at Janney Montgomery Scott
ABTX Allegiance Bancshares
$39.02 /

+ (+0.00%)

Recommendations
Intact Financial price target raised to C$185 from C$175 at TD Securities » 10:22
04/23/21
04/23
10:22
04/23/21
10:22
IFCZF

Intact Financial

$130.32 /

-0.03 (-0.02%)

TD Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IFCZF Intact Financial
$130.32 /

-0.03 (-0.02%)

02/12/21 Desjardins
Intact Financial price target raised to C$175 from C$170 at Desjardins
02/10/21 National Bank
Intact Financial price target raised to C$200 from C$192 at National Bank
02/10/21 TD Securities
Intact Financial price target raised to C$175 from C$170 at TD Securities
12/08/20 Scotiabank
Intact Financial price target raised to C$175 from C$166 at Scotiabank
Hot Stocks
GlaxoSmithKline reports European Commission approves Jemperli » 10:22
04/23/21
04/23
10:22
04/23/21
10:22
GSK

GlaxoSmithKline

$37.65 /

-0.03 (-0.08%)

GlaxoSmithKline announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GSK GlaxoSmithKline
$37.65 /

-0.03 (-0.08%)

GSK GlaxoSmithKline
$37.65 /

-0.03 (-0.08%)

04/20/21 Morgan Stanley
GlaxoSmithKline price target lowered to 1,550 GBp at Morgan Stanley
04/20/21 UBS
GlaxoSmithKline price target raised to 1,360 GBp from 1,320 GBp at UBS
04/20/21 Citi
GlaxoSmithKline collaboration with Merck would be 'win-win,' says Citi
03/23/21
Fly Intel: Top five analyst downgrades
GSK GlaxoSmithKline
$37.65 /

-0.03 (-0.08%)

GSK GlaxoSmithKline
$37.65 /

-0.03 (-0.08%)

GSK GlaxoSmithKline
$37.65 /

-0.03 (-0.08%)

GSK GlaxoSmithKline
$37.65 /

-0.03 (-0.08%)

Recommendations
Walmart+ members may have declined to 11.1M in March, says Cowen » 10:21
04/23/21
04/23
10:21
04/23/21
10:21
WMT

Walmart

$139.75 /

+0.08 (+0.06%)

Cowen analyst Oliver Chen…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WMT Walmart
$139.75 /

+0.08 (+0.06%)

WMT Walmart
$139.75 /

+0.08 (+0.06%)

04/06/21 Morgan Stanley
Walmart+ membership 'seems to have stagnated,' says Morgan Stanley
03/16/21 MKM Partners
Walmart price target lowered to $141 from $154 at MKM Partners
02/23/21 Evercore ISI
Walmart accelerating change with investments, says Evercore ISI
02/19/21 Morgan Stanley
Walmart terminal value rising with investments, says Morgan Stanley
WMT Walmart
$139.75 /

+0.08 (+0.06%)

WMT Walmart
$139.75 /

+0.08 (+0.06%)

WMT Walmart
$139.75 /

+0.08 (+0.06%)

WMT Walmart
$139.75 /

+0.08 (+0.06%)

Recommendations
Well Health Technologies price target raised to C$10.50 from C$10 at TD Securities » 10:19
04/23/21
04/23
10:19
04/23/21
10:19
WLYYF

Well Health Technologies

$5.50 /

-0.1591 (-2.81%)

TD Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WLYYF Well Health Technologies
$5.50 /

-0.1591 (-2.81%)

03/19/21 TD Securities
Well Health price target lowered to C$10 from C$11 at TD Securities
03/10/21 Desjardins
Well Health Technologies upgraded to Buy from Hold at Desjardins
02/18/21 Stifel
Well Health Technologies price target raised to C$13.50 from C$10 at Stifel
02/10/21 Desjardins
Well Health Technologies downgraded to Hold from Buy at Desjardins
Recommendations
Superior Plus price target raised to C$16.50 from C$15.50 at TD Securities » 10:19
04/23/21
04/23
10:19
04/23/21
10:19
SUUIF

Superior Plus

$11.79 /

-0.0109 (-0.09%)

TD Securities analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SUUIF Superior Plus
$11.79 /

-0.0109 (-0.09%)

05:00 Today Industrial Alliance
Superior Plus downgraded to Hold from Buy at Industrial Alliance
02/22/21 BMO Capital
Superior Plus price target raised to C$12.50 from C$12 at BMO Capital
02/19/21 TD Securities
Superior Plus price target raised to C$15.50 from C$14.50 at TD Securities
02/19/21 Scotiabank
Superior Plus price target raised to C$15 from C$13 at Scotiabank
Technical Analysis
NASDAQ market internals summary » 10:17
04/23/21
04/23
10:17
04/23/21
10:17
$NSD

NASDAQ Market Internals

/

+

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
$NSD NASDAQ Market Internals
/

+

Technical Analysis
NYSE market internals summary » 10:16
04/23/21
04/23
10:16
04/23/21
10:16
$NYE

NYSE Market Internals

/

+

Volume is average for…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
$NYE NYSE Market Internals
/

+

Hot Stocks
Sanofi announces presentation of Dupixent analyses on safety, efficacy » 10:15
04/23/21
04/23
10:15
04/23/21
10:15
SNY

Sanofi

$51.48 /

-0.57 (-1.10%)

New analyses from…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SNY Sanofi
$51.48 /

-0.57 (-1.10%)

SNY Sanofi
$51.48 /

-0.57 (-1.10%)

04/06/21 Barclays
Sanofi price target raised to EUR 85 from EUR 80 at Barclays
02/23/21 BofA
BofA adds Heineken and IAG, removes Roche and Sanofi from Europe 1 list
02/10/21 Morgan Stanley
Sanofi price target raised to EUR 104 from EUR 101 at Morgan Stanley
02/05/21 Piper Sandler
Piper reiterates Overweight on Kymera after Sanofi capital markets day
SNY Sanofi
$51.48 /

-0.57 (-1.10%)

SNY Sanofi
$51.48 /

-0.57 (-1.10%)

SNY Sanofi
$51.48 /

-0.57 (-1.10%)

General news
FX Action: The dollar » 10:15
04/23/21
04/23
10:15
04/23/21
10:15
$ECON

Economic Data

/

+

FX Action: The dollar was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
    General news
    U.S. new home sales surged 20.7% to 1,021k in March » 10:15
    04/23/21
    04/23
    10:15
    04/23/21
    10:15
    $ECON

    Economic Data

    /

    +

    U.S. new home sales…

    Story temporarily locked.
    To read stories as they happen please subscribe, Login above, or return in 9 minutes

    Get Free Trial

    ShowHide Related Items >><<
      General news
      Treasury Action: yields have jumped up » 10:15
      04/23/21
      04/23
      10:15
      04/23/21
      10:15
      $ECON

      Economic Data

      /

      +

      Treasury Action: yields…

      Story temporarily locked.
      To read stories as they happen please subscribe, Login above, or return tomorrow

      Get Free Trial

      ShowHide Related Items >><<
        Hot Stocks
        Arena Pharmaceuticals: Etrasimod 2mg group achieved SS in Phase 2b trial » 10:11
        04/23/21
        04/23
        10:11
        04/23/21
        10:11
        ARNA

        Arena Pharmaceuticals

        $67.71 /

        +0.91 (+1.36%)

        Arena Pharmaceuticals…

        Story temporarily locked.
        To read stories as they happen please subscribe, Login above, or return in 9 minutes

        Get Free Trial

        ShowHide Related Items >><<
        ARNA Arena Pharmaceuticals
        $67.71 /

        +0.91 (+1.36%)

        ARNA Arena Pharmaceuticals
        $67.71 /

        +0.91 (+1.36%)

        04/06/21 Evercore ISI
        Evercore starts 'compelling' Arena spinoff Longboard at Outperform
        03/26/21 H.C. Wainwright
        Arena Pharmaceuticals price target raised to $120 from $90 at H.C. Wainwright
        03/03/21 Cantor Fitzgerald
        Arena Pharmaceuticals price target lowered to $100 from $106 at Cantor Fitzgerald
        03/03/21 JonesTrading
        Arena Pharmaceuticals price target lowered to $94 from $101 at JonesTrading
        ARNA Arena Pharmaceuticals
        $67.71 /

        +0.91 (+1.36%)

        • 28
          May
        ARNA Arena Pharmaceuticals
        $67.71 /

        +0.91 (+1.36%)

        ARNA Arena Pharmaceuticals
        $67.71 /

        +0.91 (+1.36%)

        Hot Stocks
        Navigator Holdings awarded four handysize timecharter contracts » 10:11
        04/23/21
        04/23
        10:11
        04/23/21
        10:11
        NVGS

        Navigator Holdings

        $9.54 /

        + (+0.00%)

        Navigator Holdings…

        Story temporarily locked.
        To read stories as they happen please subscribe, Login above, or return tomorrow

        Get Free Trial

        ShowHide Related Items >><<
        NVGS Navigator Holdings
        $9.54 /

        + (+0.00%)

        NVGS Navigator Holdings
        $9.54 /

        + (+0.00%)

        01/29/21 Jefferies
        Navigator Holdings price target raised to $14 from $12 at Jefferies
        01/27/21 Evercore ISI
        Navigator Holdings downgraded to In Line from Outperform at Evercore ISI
        01/27/21 Evercore ISI
        Navigator Holdings downgraded to In Line from Outperform at Evercore ISI
        NVGS Navigator Holdings
        $9.54 /

        + (+0.00%)

        Hot Stocks
        Incyte, Lilly announce new analyses of BREEZE-AD5 Phase 3 clinical trial data » 10:10
        04/23/21
        04/23
        10:10
        04/23/21
        10:10
        INCY

        Incyte

        $84.30 /

        +0.12 (+0.14%)

        , LLY

        Eli Lilly

        $187.92 /

        +0.88 (+0.47%)

        Through new analyses of…

        Story temporarily locked.
        To read stories as they happen please subscribe, Login above, or return in 9 minutes

        Get Free Trial

        ShowHide Related Items >><<
        INCY Incyte
        $84.30 /

        +0.12 (+0.14%)

        LLY Eli Lilly
        $187.92 /

        +0.88 (+0.47%)

        INCY Incyte
        $84.30 /

        +0.12 (+0.14%)

        02/10/21 SVB Leerink
        Incyte downgraded to Market Perform from Outperform at SVB Leerink
        01/07/21 Truist
        Incyte initiated with a Buy at Truist
        01/07/21 Truist
        Incyte initiated with a Buy at Truist
        01/04/21 Guggenheim
        Incyte upgraded to Buy from Neutral at Guggenheim
        LLY Eli Lilly
        $187.92 /

        +0.88 (+0.47%)

        04/12/21 Benchmark
        Benchmark sees full FDA approval of Regeneron's REGEN-COV coming
        04/06/21 JPMorgan
        JPMorgan survey 'broadly positive' on Eli Lilly Alzheimer's drug
        03/24/21 BMO Capital
        AbCellera price target lowered to $59 from $61 at BMO Capital
        03/17/21 Mizuho
        AbbVie's FDA request show Xeljanz concerns may bleed to Rinvoq, says Mizuho
        INCY Incyte
        $84.30 /

        +0.12 (+0.14%)

        LLY Eli Lilly
        $187.92 /

        +0.88 (+0.47%)

        INCY Incyte
        $84.30 /

        +0.12 (+0.14%)

        LLY Eli Lilly
        $187.92 /

        +0.88 (+0.47%)

        INCY Incyte
        $84.30 /

        +0.12 (+0.14%)

        LLY Eli Lilly
        $187.92 /

        +0.88 (+0.47%)

        INCY Incyte
        $84.30 /

        +0.12 (+0.14%)

        LLY Eli Lilly
        $187.92 /

        +0.88 (+0.47%)

        Hot Stocks
        Arcutis Biotherapeutics presents roflumilast safety, efficacy data » 10:09
        04/23/21
        04/23
        10:09
        04/23/21
        10:09
        ARQT

        Arcutis Biotherapeutics

        $30.58 /

        -0.34 (-1.10%)

        Arcutis Biotherapeutics…

        Story temporarily locked.
        To read stories as they happen please subscribe, Login above, or return tomorrow

        Get Free Trial

        ShowHide Related Items >><<
        ARQT Arcutis Biotherapeutics
        $30.58 /

        -0.34 (-1.10%)

        ARQT Arcutis Biotherapeutics
        $30.58 /

        -0.34 (-1.10%)

        02/02/21 Truist
        Arcutis Biotherapeutics price target raised to $48 from $38 at Truist
        02/01/21 Cowen
        Arcutis Biotherapeutics price target raised to $80 from $55 at Cowen
        01/28/21 JonesTrading
        Arcutis Biotherapeutics initiated with a Buy at JonesTrading
        11/09/20 Goldman Sachs
        Arcutis Biotherapeutics upgraded to Buy from Neutral at Goldman Sachs
        ARQT Arcutis Biotherapeutics
        $30.58 /

        -0.34 (-1.10%)

        • 03
          Feb
        • 02
          Oct
        ARQT Arcutis Biotherapeutics
        $30.58 /

        -0.34 (-1.10%)

        ARQT Arcutis Biotherapeutics
        $30.58 /

        -0.34 (-1.10%)

        Hot Stocks
        Eli Lilly reports on clinical trial meta-analysis of Taltz » 10:08
        04/23/21
        04/23
        10:08
        04/23/21
        10:08
        LLY

        Eli Lilly

        $188.00 /

        +0.96 (+0.51%)

        Eli Lilly reports that…

        Story temporarily locked.
        To read stories as they happen please subscribe, Login above, or return in 9 minutes

        Get Free Trial

        ShowHide Related Items >><<
        LLY Eli Lilly
        $188.00 /

        +0.96 (+0.51%)

        LLY Eli Lilly
        $188.00 /

        +0.96 (+0.51%)

        04/12/21 Benchmark
        Benchmark sees full FDA approval of Regeneron's REGEN-COV coming
        04/06/21 JPMorgan
        JPMorgan survey 'broadly positive' on Eli Lilly Alzheimer's drug
        03/24/21 BMO Capital
        AbCellera price target lowered to $59 from $61 at BMO Capital
        03/17/21 Mizuho
        AbbVie's FDA request show Xeljanz concerns may bleed to Rinvoq, says Mizuho
        LLY Eli Lilly
        $188.00 /

        +0.96 (+0.51%)

        LLY Eli Lilly
        $188.00 /

        +0.96 (+0.51%)

        LLY Eli Lilly
        $188.00 /

        +0.96 (+0.51%)

        LLY Eli Lilly
        $188.00 /

        +0.96 (+0.51%)

        Hot Stocks
        Brickell Biotech reports results from ARGYLE phase 3 study » 10:07
        04/23/21
        04/23
        10:07
        04/23/21
        10:07
        BBI

        Brickell Biotech

        /

        +

        Brickell Biotech…

        Story temporarily locked.
        To read stories as they happen please subscribe, Login above, or return tomorrow

        Get Free Trial

        ShowHide Related Items >><<
        BBI Brickell Biotech
        /

        +

        BBI Brickell Biotech
        /

        +

        09/25/20 Lake Street
        Approval in Japan validating for Brickell Biotech, says Lake Street
        08/28/20 Lake Street
        Brickell Biotech initiated with a Buy at Lake Street
        08/25/20 Oppenheimer
        Brickell Biotech initiated with an Outperform at Oppenheimer
        • 23
          Oct
        • 18
          Jun

        Get Full Fly Access

        Breaking market intelligence sent straight to you
        Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
        Up-to-date information on important industry events
        Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
        News focused on the companies in your portfolio
        Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.